Global C-Reactive Protein Test (CRP) Market Forecast, Trend Analysis And Competition Tracking - Global Market insights 2015 to 2031

C-Reactive Protein Test (CRP) Market Introduction:

The C-Reactive Protein Test (CRP) is a blood test that can provide information about acute systemic inflammation in the body. The CRP is used to measure the response of the body's immune system to an infection or inflammatory condition. Higher levels of CRP are generally seen in people who have an assortment of conditions including rheumatoid arthritis, chronic obstructive pulmonary disease, depression, and hepatitis.

Request Covid - 19 Impact

The normal CRP concentration levels range from 3-5 mg/L. CRP levels appear to be elevated in people infected with SARS-CoV-2, the virus that causes COVID-19. Severe COVID-19 infection leads to overproduction of inflammatory cytokines and interleukins. Excessive production of inflammatory cytokines can lead to elevated CRP levels. Cytokines fight pathogens, but when the system is in overactive mode, it damages lung tissue. Elevated CRP levels may be a valuable early marker for predicting the likelihood of disease progression in non-severe COVID-19 patients, which could help health workers identify these patients at an early stage for early treatment. In addition, patients with COVID-19 with elevated CRP levels require close monitoring and treatment even if they do not have symptoms that meet criteria for a severe course.

Global C-Reactive Protein Test (CRP) Market Revenue Outlook:

The Global C-Reactive Protein Test (CRP) Market was valued at US$ 585.6 Mn in 2020 and is also projected to register а САGR of 5.8% by 2031.

Increasing awareness and adoption of C-Reactive Protein Test (CRP) in several countries

The prevalence of the cardiovascular disease is increasing. This is thought to be due to an increase in the incidence, or new cases, of chronic cardiovascular risk factors such as hypertension and diabetes. This clinical trial demonstrated that CRP levels are associated with the development of atherosclerotic cardiovascular disease. The C-reactive protein (CRP) is an acute-phase reactant that is released in the bloodstream when the immune system becomes activated. The presence of elevated levels of CRP is typically indicative of an inflammatory condition, such as cardiovascular disease, especially among those at high risk for cardiovascular events. A higher level of CRP indicates a higher risk of future cardiovascular events, which can help doctors make recommendations for preventative measures.

The high cost of CRP instruments is the key challenge to the C-Reactive Protein Test (CRP) market

The high cost of CRP test instruments may restrain the C-Reactive Protein Test (CRP) market because many patients cannot afford the expensive tests. C-reactive protein is a chemical produced by liver cells associated with inflammation, infection, sepsis, and autoimmune disorders. Doctors are increasingly using these tests to diagnose anemia, chronic kidney disease, or inflammatory bowel disease.

Key opportunities for the revenue growth in the C-Reactive Protein Test (CRP) market

The C-Reactive Protein Test (CRP) market constitutes the revenue generated by the commercialization of products in the market. The revenue growth for this market depends on the increase in the number of healthcare providers ordering CRP tests and an increase in demand for these tests. Other factors which contribute to revenue growth are an increase in the number of patients with chronic diseases and a decrease in pricing pressures.

Global C-Reactive Protein Test (CRP) Market Regional Analysis

North America and Europe region is expected to have a significant market share among others

The C-Reactive Protein Test (CRP) is a measurement of the level of inflammation in the body. North America and Europe dominate the market due to their more sophisticated healthcare systems that are able to provide care for patients with chronic inflammatory conditions. Currently, North America generates the most revenue from CRP testing, with an annual growth rate of XX%.

The Asia-Pacific region is also expected to grow at a higher pace in the CRP test market due to their high population density and ever-growing demand for quality healthcare. Historically, Asia-Pacific region has been known for its healthy environment and low rates of chronic disease, but the prevalence of noncommunicable diseases has risen exponentially. This rise in chronic disease coupled with a lack of investment in healthcare systems is resulting in an increased risk of mortality. The growth in the Asia-Pacific region is mainly attributed to the introduction of new players. In addition, China's growing middle class and its demand for more quality healthcare services will lead to higher adoption of CRP tests in the country.

Competitive Landscape For Global C-Reactive Protein Test (CRP) Market

List of the major leading players operating in the Global C-Reactive Protein Test (CRP) Market are mentioned below:

• Thermo Fisher Scientific, inc.
• Hoffmann-La Roche Ltd.
• Danaher
• Quest Diagnostics
• Siemens Healthineers AG
• Abbott
• Merck KGaAA
• Zoetis
• Ortho Clinical Diagnostics
• Getein Biotech, Inc.
• HORIBA, Ltd
• Randox Laboratories Ltd.
• BODITECH MED, INC.
• Aidian
• Other Key Industry Players

Report Scope

• Forecast Period: 2022-2031
• Actual Year: 2021
• Historical Data Available for: 2015-2020

Key Segments Covered

Global C-Reactive Protein Test (CRP) Market, By Type

• Kits
• Reagents

Global C-Reactive Protein Test (CRP) Market, By Application

• Cardiovascular Diseases
• Infections
• Diseases Of Immune System
• Rhematoid Arthritis
• Cancers
• Inflammatory Bowel Disease
• Osteomyelitis
• Other Applications

Global C-Reactive Protein Test (CRP) Market, By Assay Type

• ELISA
• Immunoturbidimetric
• Chemiluminesence immunoassay(CLIA)
• High-sensitivity C-reactive protein (hsCRP) Assay

Global C-Reactive Protein Test (CRP) Market, By End-Use

• Hospitals
• Laboratories
• Healthcare Facilities
• Other End-Uses